FNDC5 and Cognitive impairment: Cerebrospinal fluid (CSF) and serum irisin levels were evaluated using enzyme‐linked immunoassays in a cohort of subjects with a confirmed biomarker evidence of AD, including AD (n = 82), mild cognitive impairment (MCI, n = 44), and subjective memory complaint (SMC, n = 20) patients.